- Login
- Manage Portfolio
- Post a StockTalk
- Write an Instablog
- Get Daily Email Alert
-
Seeking Alpha
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: | |
-
Study of Sepracor’s Depression Drug Has Investors Gloomy
-
A Healthy Dose of Funding for Pharma, Biotech
-
Wall Street Breakfast: Must-Know News
-
Does More Cash and Less Debt Equal Stock Market Gains?
-
Wednesday Options Update: GM, JNPR, ROK, TGT, TCK, VIX
-
FDA and Clinical Trial Updates: Weight Loss, Diabetes and More
-
Where Might Genentech Investors Redeploy $47B?
-
Thursday Options Update: GE, CX, GME, SEPR, ADBE
-
Wall Street Breakfast: Must-Know News
-
Earnings Preview: Sepracor
-
Hedge Fund Portfolio Tracking: SAC Capital (Steven Cohen), Q3 2008
-
Earnings Preview: Sepracor
-
Earnings Preview: Sepracor
-
Wall Street Breakfast: Must-Know News
-
Ten Companies Involved in Treating Asthma
-
Healthcare Stocks Have Been Anything but Defensive
-
Pfizer Should Buy Amgen or Wyeth - Credit Suisse
-
Pfizer, J&J Would Be Front Runners in a Sepracor Buyout
-
Nasdaq 100 Adds Five Companies in Annual Rebalance
-
Ericsson, XMSR Leave Nasdaq; Focus Media, Hansen Among Joiners
-
Nasdaq 100's Top 25 PEG Plays
-
This Week's Key Earnings Reports
-
Valuing Sepracor Through Astra-Zeneca's MedImmune Goggles
-
Biotech Day In Review: NPS Cuts Staff Again
-
FDA Issues New Warning Label Requirement for Sleeping Pills
-
Biotech Day in Review: AstraZeneca Buys Arrow Therapeutics
-
Biotech Day In Review: AstraZeneca Enters Two Partnerships Worth $800 Million
-
Sepracor: Takeover Target From Pharma Major?
-
Updated WSJ Options Scandal Scorecard
-
Earnings Schedule and Estimates for Friday, July 21, 2006
-
WSJ Options Scandal Scorecard
-
Nasdaq 100 Stocks Above Their Moving Averages
-
Rob Black's Healthcare Stock Report
-
Sepracor: Pfizer Rumors Spur Options Speculation (PFE, SEPR)
-
Evaluating the Implosion in Neurocrine Biosciences (NBIX, DOVP, SEPR, KG)
-
One Page Barron's Summary
-
Sepracor Acquisition: Not If But When (SEPR)
-
Amgen Makes Bid To Acquire Abgenix For $2.2 billion (AMGN, ABGX)